๏ธ๐บ๐ธ Reuters: Anthropic has quietly built a wet lab for physical biology experiments in the San Francisco Bay Area as it expands its AI-driven drug development ambitions beyond computer simulations, with its head of life sciences, Eric Kauderer-Abrams, confirming the facility and saying the company aims for its Claude AI units to make limited intervention in a human lab.
The company said it would stop running clinical trials to avoid competing with drug companies, instead focusing on terms it sees as commercially unattractive for traditional drugmakers, while continuing to ramp up procurement and recruiting for the effort following its early purchase of Coefficient Bio and the addition of Novartis CEO Vas Narasimhan to its board.